XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Convertible preferred stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-In Capital
Accumulated Deficit
Class A Common Stock
Class B Common Stock
Total
Convertible Preferred Stock, Balance at beginning of the period at Dec. 31, 2019 $ 360,937              
Convertible Preferred Stock, Balance at beginning of the period (in shares) at Dec. 31, 2019 107,197,118              
Convertible Preferred Stock, Balance at end of the period at Mar. 31, 2020 $ 360,937              
Convertible Preferred Stock, Balance at end of the period (in shares) at Mar. 31, 2020 107,197,118              
Balance at beginning of the period at Dec. 31, 2019       $ 19,782 $ (232,061) $ 1   $ (212,278)
Balance at beginning of the period (in shares) at Dec. 31, 2019   5,939,950            
Increase (Decrease) in Stockholders' Equity                
Net loss         (24,354)     (24,354)
Common stock issued upon exercise of stock options       154       154
Common stock issued upon exercise of stock options (in shares)   73,515            
Stock-based compensation expense       2,697       2,697
Balance at end of the period at Mar. 31, 2020       22,633 (256,415) 1   (233,782)
Balance at end of the period (in shares) at Mar. 31, 2020   6,013,465            
Convertible Preferred Stock, Balance at beginning of the period at Dec. 31, 2019 $ 360,937              
Convertible Preferred Stock, Balance at beginning of the period (in shares) at Dec. 31, 2019 107,197,118              
Convertible Preferred Stock, Balance at end of the period at Dec. 31, 2020 $ 360,937             360,937
Convertible Preferred Stock, Balance at end of the period (in shares) at Dec. 31, 2020 107,197,118              
Balance at beginning of the period at Dec. 31, 2019       19,782 (232,061) 1   (212,278)
Balance at beginning of the period (in shares) at Dec. 31, 2019   5,939,950            
Increase (Decrease) in Stockholders' Equity                
Conversion of convertible debt               49,900
Balance at end of the period at Dec. 31, 2020       32,874 (394,806) $ 1   (361,931)
Balance at end of the period (in shares) at Dec. 31, 2020   6,593,291       6,593,291 0  
Increase (Decrease) in Stockholders' Equity                
Conversion of convertible preferred stock $ (360,937)              
Conversion of convertible preferred stock (in shares) (107,197,118)              
Net loss         (690)     (690)
Common stock issued upon exercise of stock options       6,313       6,313
Common stock issued upon exercise of stock options (in shares)   3,155,050            
Conversion of convertible preferred stock     $ 3 360,926   $ 8   360,937
Conversion of convertible preferred stock (in shares)   80,770,178 26,426,939          
Conversion of convertible debt       49,916   1   49,917
Conversion of convertible debt (in shares)   5,115,140            
Net equity infusion from the Business Combination       361,281   6   361,287
Net equity infusion from the Business Combination (in shares)   69,228,811            
Stock-based compensation expense       20,330       20,330
Balance at end of the period at Mar. 31, 2021     $ 3 $ 831,640 $ (395,496) $ 16   $ 436,163
Balance at end of the period (in shares) at Mar. 31, 2021   164,862,470 26,426,939     164,862,470 26,426,939